ReviewRhode Island medical journal (2013)2014
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
Review in Rhode Island medical journal (2013), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- GLP-1 Receptor Agonists: Encouraging Signals for Treating Alcohol Use Disorder.Journal of general internal medicine · 2025Article
- Physicians' attitudes towards patients with substance-related disorders predict training needs in addiction medicine: challenges and opportunities for strengthening the global addiction medicine workforce.BMC medical education · 2025Article
- Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.JAMA network open · 2025Article
- Surgeons' Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis.The Annals of thoracic surgery · 2023Article
- Towards a framework for implementing physician education in substance use disorders.Drug and alcohol dependence reports · 2021Article
- Naltrexone-induced drug eruption.Clinical case reports · 2020Article
- Increasing Prevalence of Alcohol Use Disorders: Meeting the Challenge in Primary Care : Commentary on Williams et al., Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.Journal of general internal medicine · 2018Article
- A Needs Assessment of the Number of Comprehensive Addiction Care Physicians Required in a Canadian Setting.Journal of addiction medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Substance use disorders are a leading cause of morbidity and mortality in the United States. Medications for the treatment of substance use disorders are effective yet underutilized. This article reviews recent literature examining medications used for the treatment of alcohol and opioid use disorders. The neurobehavioral rationale for medication treatment and the most common ways medications work in the treatment of substance use disorders are discussed. Finally, the medications and the evidence behind their effectiveness are briefly reviewed. Physicians and other prescribing clinicians should take an active role in facilitating remission and recovery from substance use disorders by prescribing these effective medications with brief medical management counseling.
Indexed as
Identifiers
25271655PMC4406629What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.